Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Neoplasms 9Esophageal Squamous Cell Carcinoma 8Squamous Cell Carcinoma of Head and Neck 7Uterine Cervical Neoplasms 6Pancreatic Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 2Pancreatic cancer, adult 2Lung Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Uterine Cervical Dysplasia 1Squamous Cell Carcinoma of Anal Canal 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Locally Advanced Rectal Cancer 1Hypopharyngeal Neoplasms 1HCC 1Glioma 1Glioblastoma 1Esophageal 1Colorectal Neoplasms 1Childhood Brain Stem Neoplasm 1

Interventions

Cisplatin 39Radiotherapy 21Carboplatin 21Cetuximab 20Paclitaxel 19Docetaxel 17Radiotherapy, Intensity-Modulated 15pembrolizumab 14Fluorouracil 13Drug Therapy 10Nivolumab 8Radiation 6cemiplimab 5atezolizumab 5Panitumumab 5Oxaliplatin 5Erlotinib Hydrochloride 5Chemoradiotherapy 5Afatinib 5Surgical Procedures, Operative 4durvalumab 3Surveys and Questionnaires 3Methotrexate 3Leucovorin 3Lapatinib 3130-nm albumin-bound paclitaxel 3toripalimab 2palbociclib 2osimertinib 2dacomitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Squamous Cell × nimotuzumab × Clear all
NCT01232374 2015-08-20

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 2 Unknown
144 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡